Updates | ClinRegs

New Requirements Issued by China's NMPA

Aug 18, 2020 - China’s National Medical Products Administration (NMPA) has recently released the following requirements, which the ClinRegs team is reviewing and will incorporate into the China profile this year. Drug Clinical Trial Registration and Information Disclosure Management (No. ...

New Requirements Issued by China's NMPA

Aug 6, 2020 - China’s National Medical Products Administration (NMPA) has updated their website, which has resulted in a number of broken links in the China country profile. The ClinRegs team is working to identify and replace these links. In addition, the NMPA has recently released the following ...

Brazil: ANVISA Issues Updated Guidelines Related to COVID-19 and Clinical Trials

Aug 4, 2020 - On July 28, 2020, Brazil’s National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária (ANVISA)) issued an updated technical note providing guidance to sponsors, centers, and researchers related to clinical research and COVID-19. The ...

Mali Profile Reviewed

Jul 23, 2020 - The Mali profile in ClinRegs has been reviewed to ensure all information is up-to-date and accurate. ...

Guinea Profile Reviewed

Jul 17, 2020 - The Guinea profile in ClinRegs has been reviewed to ensure all information is up-to-date and accurate. ...

China Profile Updated in ClinRegs

Jul 7, 2020 - The China profile in ClinRegs now includes the National Medical Products Administration’s (NMPA) revised Measures for the Administration of Drug Registration, which took effect July 1, 2020. Please note that NMPA has also released the following requirements which took ...

Peru: INS Issues Guidelines for Clinical Trials during COVID-19 Emergency

Jul 7, 2020 - On June 26, 2020, Peru’s National Institute of Health (Instituto Nacional de Salud (INS)) issued Guidelines for the Conduct of Clinical Trials during the Health Emergency Due to COVID-19. The guidelines aim to assist sponsors in assuring the safety of trial participants, maintaining ...